CLOs on the Move

Vicor Technology

www.vicortech.com

 
Frp, Web: Vicor Technologies, Inc (OTCBB: VCRT) is a bio-technology company focused on the development and commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients: •at risk of sudden cardiac death or autonomic nervous system dysfunction, and •trauma victims in need of immediate lifesaving intervention.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.vicortech.com
  • 2300 NW Corporate Blvd Ste 123
    Boca Raton, FL USA 33431
  • Phone: 800.998.9964

Executives

Name Title Contact Details

Similar Companies

Jefferson Radiology

Excerpted from the website description: Jefferson Radiology Group is a partnership of more than 30 radiologists, offering Sub-Specialized diagnostic and interventional imaging services. All the physicians in the Group, who are Board Certified, are committed to delivering the highest quality of radiology and imaging services as possible.

BE Medical

BE Medical is a Kendall Park, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Summit Dental Systems

Summit Dental Systems is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OrthoPediatrics Corp

OrthoPediatrics Corp is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

LumiThera

At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company`s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological “drusen” following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area. The Valeda Light Delivery System is CE Marked. The device is not for sale in the USA.